Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma

Transforming Growth Factor-  as a Therapeutic Target in Hepatocellular Carcinoma

(2014) G. Giannelli et al.   CANCER RESEARCH

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma

(2013) Hsin-Jung Lee et al.   CARCINOGENESIS

αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma

(2013) Xiao-Yong Huang et al.   HEPATOLOGY

TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases

(2013) Koichi Matsuzaki et al.   JOURNAL OF GASTROENTEROLOGY

Biology of the TAM Receptors

(2013) G. Lemke   Cold Spring Harbor Perspectives in Biology

Phospho-specific Smad3 signaling

(2012) Elizabeth Tarasewicz et al.   CELL CYCLE

TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver Carcinoma

(2012) Patrick Reichl et al.   CURRENT PHARMACEUTICAL DESIGN

Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy

(2012) Seok-Hyung Kim et al.   Hepatobiliary & Pancreatic Diseases International

Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis

(2012) Thomas Bauer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium

(2011) Jung Eun Choi et al.   CANCER LETTERS

Smad phosphoisoform signaling specificity: the right place at the right time

(2011) Koichi Matsuzaki   CARCINOGENESIS

Role of Smads in TGFβ signaling

(2011) Carl-Henrik Heldin et al.   CELL AND TISSUE RESEARCH

Axl-dependent signalling: a clinical update

(2011) Vyacheslav A. Korshunov   CLINICAL SCIENCE

A Human Model of Epithelial to Mesenchymal Transition to Monitor Drug Efficacy in Hepatocellular Carcinoma Progression

(2011) F. van Zijl et al.   MOLECULAR CANCER THERAPEUTICS

Post-translational modification of 14-3-3 isoforms and regulation of cellular function

(2011) Alastair Aitken   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Structural basis of 14-3-3 protein functions

(2011) Tomas Obsil et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1

(2010) Hye-Young Hong et al.   MOLECULES AND CELLS

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma

(2010) M Z Xu et al.   ONCOGENE

Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence

(2009) Gudrun Zulehner et al.   AMERICAN JOURNAL OF PATHOLOGY

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Modulation of TGF-beta signaling during progression of chronic liver diseases

(2009) Koichi Matsuzaki   Frontiers in Bioscience-Landmark

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

(2009) C. Gjerdrum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression

(2008) Y.-X. Zhang et al.   CANCER RESEARCH

TGFβ in Cancer

(2008) Joan Massagué   CELL